NEBIVOLOL

NEBIVOLOL was reported 34143 times

NEBIVOLOL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CARDIOPULMONARY EXERCISE TEST ABNORMAL 13 0.4643
1 TRAUMATIC COMA 11 0.3143
2 MENISCOPATHY 12 0.2667
3 PELVIC MISALIGNMENT 12 0.2353
4 FACTOR VII DEFICIENCY 14 0.2090
5 PERONEAL NERVE INJURY 13 0.1150
6 SACROILIAC JOINT DYSFUNCTION 13 0.0977
7 NEUROFIBROMA 14 0.0933
8 CEREBELLAR ISCHAEMIA 15 0.0806
9 ACUTE MOTOR-SENSORY AXONAL NEUROPATHY 17 0.0739
10 THERAPEUTIC DRUG MONITORING ANALYSIS NOT PERFORMED 19 0.0644
11 ENTEROBACTER PNEUMONIA 10 0.0641
12 CARDIAC MYXOMA 12 0.0550
13 MERYCISM 14 0.0490
14 RENAL ARTERY THROMBOSIS 13 0.0421
15 HYPOPARATHYROIDISM 29 0.0378
16 FUNGAL ENDOCARDITIS 11 0.0365
17 ORTHOSTATIC INTOLERANCE 26 0.0362
18 MYOSCLEROSIS 12 0.0325
19 CERVICOBRACHIAL SYNDROME 18 0.0294
20 PATELLOFEMORAL PAIN SYNDROME 14 0.0272
21 HELICOBACTER TEST POSITIVE 15 0.0268
22 VESTIBULAR NEURONITIS 14 0.0262
23 NEUROGENIC SHOCK 13 0.0240
24 RENAL ISCHAEMIA 13 0.0238
25 PRODUCT MONITORING ERROR 33 0.0228
26 VASCULAR PURPURA 31 0.0222
27 INFECTIVE EXACERBATION OF CHRONIC OBSTRUCTIVE AIRWAYS DISEASE 14 0.0218
28 BURNOUT SYNDROME 12 0.0211
29 HAEMATOMA MUSCLE 25 0.0209
30 STASIS DERMATITIS 14 0.0205
31 SYSTEMIC INFECTION 29 0.0175
32 OSTEOCHONDROSIS 20 0.0172
33 RESTING TREMOR 11 0.0170
34 CEREBELLAR ATAXIA 16 0.0167
35 CUTANEOUS LUPUS ERYTHEMATOSUS 32 0.0165
36 OBSTRUCTIVE SLEEP APNOEA SYNDROME 24 0.0164
37 BLADDER TRANSITIONAL CELL CARCINOMA 23 0.0161
38 N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED 22 0.0157
39 EXTENSOR PLANTAR RESPONSE 14 0.0152
40 INTRACRANIAL MASS 14 0.0148
41 HYPOCHROMIC ANAEMIA 15 0.0148
42 SOLAR LENTIGO 14 0.0148
43 PERIPHERAL MOTOR NEUROPATHY 20 0.0143
44 SINUS ARREST 22 0.0140
45 CEREBRAL HAEMATOMA 47 0.0140
46 FOLATE DEFICIENCY 16 0.0138
47 CAROTID ARTERIOSCLEROSIS 14 0.0136
48 ATYPICAL HAEMOLYTIC URAEMIC SYNDROME 11 0.0135
49 AORTIC DILATATION 15 0.0135
50 BLOOD UREA ABNORMAL 12 0.0128
51 POTENTIATING DRUG INTERACTION 42 0.0125
52 NORMOCYTIC ANAEMIA 18 0.0122
53 AKINESIA 25 0.0121
54 HYPOMAGNESAEMIA 163 0.0117
55 RENAL ARTERY STENOSIS 16 0.0116
56 SINUS NODE DYSFUNCTION 21 0.0115
57 PRERENAL FAILURE 16 0.0113
58 GLOMERULAR FILTRATION RATE ABNORMAL 16 0.0113
59 HAEMORRHAGIC TRANSFORMATION STROKE 17 0.0113
60 ACQUIRED HAEMOPHILIA 11 0.0110
61 RENAL TUBULAR DISORDER 30 0.0107
62 MICROCYTIC ANAEMIA 22 0.0106
63 MONOPARESIS 19 0.0105
64 ACTINIC KERATOSIS 27 0.0104
65 HYPERTENSIVE EMERGENCY 12 0.0102
66 POLYCYTHAEMIA 21 0.0102
67 AORTIC VALVE STENOSIS 18 0.0101
68 ALVEOLITIS ALLERGIC 10 0.0097
69 SUBCLAVIAN VEIN THROMBOSIS 11 0.0097
70 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 85 0.0096
71 PULMONARY VALVE INCOMPETENCE 14 0.0096
72 RETROPERITONEAL HAEMATOMA 21 0.0095
73 TROPONIN T INCREASED 12 0.0095
74 BLOOD SODIUM ABNORMAL 10 0.0094
75 CARDIAC FAILURE CHRONIC 40 0.0094
76 MICROCEPHALY 12 0.0094
77 ARRHYTHMIA SUPRAVENTRICULAR 10 0.0091
78 HYPERKALAEMIA 321 0.0091
79 BRADYARRHYTHMIA 15 0.0091
80 NEOPLASM SKIN 14 0.0090
81 HYPERTENSIVE CRISIS 99 0.0089
82 KNEE DEFORMITY 13 0.0087
83 DIABETIC NEPHROPATHY 19 0.0086
84 BLOOD CREATINE PHOSPHOKINASE MB INCREASED 11 0.0086
85 CARDIOVASCULAR INSUFFICIENCY 14 0.0086
86 CORONARY ARTERY STENOSIS 43 0.0085
87 HYPOCHLORAEMIA 10 0.0085
88 GLOMERULONEPHRITIS MEMBRANOUS 10 0.0085
89 ELECTROCARDIOGRAM T WAVE ABNORMAL 13 0.0083
90 CRANIOCEREBRAL INJURY 25 0.0083
91 INTERMITTENT CLAUDICATION 13 0.0082
92 VITAMIN B12 DECREASED 23 0.0080
93 WRONG PATIENT RECEIVED PRODUCT 23 0.0079
94 MYOGLOBIN BLOOD INCREASED 12 0.0078
95 SKIN EROSION 25 0.0078
96 SUPRAVENTRICULAR EXTRASYSTOLES 26 0.0077
97 ACUTE ABDOMEN 11 0.0075
98 LICHEN PLANUS 17 0.0073
99 BRADYCARDIA 387 0.0073
100 CUTANEOUS VASCULITIS 26 0.0071
101 HYPOVOLAEMIC SHOCK 34 0.0071
102 OPTIC NEUROPATHY 15 0.0071
103 HYPERLACTACIDAEMIA 19 0.0071
104 LACTIC ACIDOSIS 227 0.0070
105 PERIODONTITIS 15 0.0069
106 HEPATITIS TOXIC 18 0.0069
107 ESCHERICHIA SEPSIS 20 0.0069
108 SHOCK HAEMORRHAGIC 56 0.0069
109 HYPOCALCAEMIA 130 0.0069
110 ARTERIAL THROMBOSIS 13 0.0067
111 LIVEDO RETICULARIS 14 0.0067
112 CHOLESTASIS 128 0.0067
113 ELECTROCARDIOGRAM ABNORMAL 52 0.0066
114 EXERCISE TOLERANCE DECREASED 38 0.0066
115 PERIARTHRITIS 15 0.0066
116 COLITIS MICROSCOPIC 31 0.0065
117 ACUTE KIDNEY INJURY 994 0.0065
118 COAGULATION TIME PROLONGED 10 0.0065
119 STAPHYLOCOCCAL BACTERAEMIA 28 0.0064
120 CEREBELLAR SYNDROME 14 0.0064
121 ATRIOVENTRICULAR BLOCK 49 0.0063
122 HYPERAMMONAEMIC ENCEPHALOPATHY 11 0.0063
123 IDIOPATHIC PULMONARY FIBROSIS 25 0.0063
124 EOSINOPHILIA 110 0.0063
125 ATRIOVENTRICULAR BLOCK COMPLETE 42 0.0063
126 MIGRAINE WITH AURA 17 0.0063
127 CONGESTIVE CARDIOMYOPATHY 26 0.0062
128 HEPATIC MASS 12 0.0062
129 ATRIAL TACHYCARDIA 13 0.0062
130 KOUNIS SYNDROME 14 0.0062
131 LIP OEDEMA 26 0.0061
132 BUNDLE BRANCH BLOCK LEFT 26 0.0061
133 FEBRILE BONE MARROW APLASIA 26 0.0061
134 HYPONATRAEMIA 343 0.0061
135 ORTHOSTATIC HYPOTENSION 106 0.0061
136 BLOOD CREATININE ABNORMAL 21 0.0061
137 KIDNEY TRANSPLANT REJECTION 29 0.0060
138 INTRAVENTRICULAR HAEMORRHAGE 15 0.0060
139 EXTRASYSTOLES 42 0.0060
140 HYPERCAPNIA 18 0.0060
141 ANURIA 51 0.0059
142 SPINAL OSTEOARTHRITIS 52 0.0059
143 ISCHAEMIC STROKE 105 0.0059
144 ADENOCARCINOMA OF COLON 11 0.0059
145 HYPERPARATHYROIDISM 12 0.0058
146 SINUS BRADYCARDIA 56 0.0058
147 TONGUE OEDEMA 22 0.0058
148 HYPOKALAEMIA 261 0.0056
149 BLOOD POTASSIUM ABNORMAL 15 0.0056
150 ANGINA PECTORIS 161 0.0056
151 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 57 0.0055
152 ELECTROLYTE IMBALANCE 64 0.0055
153 HEPATOCELLULAR INJURY 78 0.0055
154 TRICUSPID VALVE INCOMPETENCE 43 0.0054
155 PARESIS 12 0.0054
156 CHRONIC GASTRITIS 12 0.0053
157 SNORING 20 0.0053
158 LEFT VENTRICULAR FAILURE 18 0.0052
159 VENTRICULAR ARRHYTHMIA 19 0.0052
160 AORTIC VALVE INCOMPETENCE 22 0.0052
161 CHONDROPATHY 14 0.0052
162 ACUTE PULMONARY OEDEMA 29 0.0052
163 ANAEMIA MACROCYTIC 11 0.0051
164 GASTRITIS EROSIVE 24 0.0051
165 BLOOD LACTIC ACID INCREASED 27 0.0051
166 EPIGASTRIC DISCOMFORT 20 0.0051
167 EXOPHTHALMOS 11 0.0051
168 BICYTOPENIA 10 0.0051
169 HEPATIC CYTOLYSIS 65 0.0051
170 LANGUAGE DISORDER 11 0.0051
171 SMALL FOR DATES BABY 25 0.0050
172 CARDIOGENIC SHOCK 72 0.0050
173 MIXED LIVER INJURY 15 0.0050
174 VENTRICULAR HYPOKINESIA 16 0.0050
175 PEMPHIGOID 37 0.0049
176 DUODENAL ULCER HAEMORRHAGE 14 0.0049
177 BRAIN NATRIURETIC PEPTIDE INCREASED 15 0.0049
178 MELAENA 107 0.0049
179 POISONING DELIBERATE 46 0.0048
180 DYSPNOEA AT REST 14 0.0048
181 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 124 0.0048
182 HAEMORRHAGIC ANAEMIA 21 0.0048
183 DILATATION VENTRICULAR 10 0.0048
184 HAEMORRHAGIC STROKE 37 0.0047
185 VENTRICULAR EXTRASYSTOLES 49 0.0047
186 SPRUE-LIKE ENTEROPATHY 23 0.0047
187 CACHEXIA 24 0.0047
188 METABOLIC ACIDOSIS 148 0.0046
189 URINE OUTPUT INCREASED 12 0.0046
190 OESOPHAGITIS 50 0.0046
191 HYPERSENSITIVITY VASCULITIS 12 0.0046
192 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 15 0.0045
193 FACIAL PARESIS 16 0.0045
194 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 18 0.0044
195 PERIPHERAL ISCHAEMIA 18 0.0044
196 PERIPHERAL VENOUS DISEASE 18 0.0044
197 HYPERURICAEMIA 18 0.0044
198 PLATELET DISORDER 11 0.0044
199 ACUTE CORONARY SYNDROME 36 0.0043
200 TROPONIN INCREASED 33 0.0043
201 BLOOD URIC ACID INCREASED 25 0.0043
202 GLOMERULAR FILTRATION RATE DECREASED 53 0.0043
203 SEDATION COMPLICATION 11 0.0043
204 ANAL HAEMORRHAGE 12 0.0043
205 BENIGN PROSTATIC HYPERPLASIA 22 0.0043
206 DIABETIC FOOT 13 0.0042
207 ESCHERICHIA URINARY TRACT INFECTION 18 0.0042
208 RETINAL DISORDER 11 0.0042
209 DIASTOLIC DYSFUNCTION 13 0.0042
210 ENURESIS 17 0.0042
211 CARDIAC FAILURE ACUTE 28 0.0042
212 FAECALOMA 23 0.0042
213 DUODENAL ULCER 29 0.0041
214 DRUG INTERACTION 649 0.0041
215 RECALLED PRODUCT ADMINISTERED 39 0.0041
216 SOPOR 54 0.0041
217 HAEMODYNAMIC INSTABILITY 31 0.0041
218 SUDDEN DEATH 43 0.0041
219 PNEUMONIA FUNGAL 16 0.0041
220 TUBULOINTERSTITIAL NEPHRITIS 76 0.0041
221 PANCREATITIS ACUTE 91 0.0040
222 RASH MACULO-PAPULAR 90 0.0040
223 HAEMATOMA 104 0.0040
224 LUNG ADENOCARCINOMA 12 0.0040
225 ERYSIPELAS 20 0.0040
226 DYSLIPIDAEMIA 20 0.0039
227 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 13 0.0039
228 RHABDOMYOLYSIS 164 0.0039
229 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 20 0.0039
230 MELANOCYTIC NAEVUS 17 0.0039
231 MUSCLE RUPTURE 15 0.0038
232 RED CELL DISTRIBUTION WIDTH INCREASED 16 0.0038
233 INFLAMMATORY MARKER INCREASED 19 0.0038
234 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 10 0.0038
235 RESPIRATORY ACIDOSIS 15 0.0038
236 DRUG LEVEL INCREASED 63 0.0038
237 AORTIC STENOSIS 13 0.0037
238 HYPERCHOLESTEROLAEMIA 36 0.0037
239 HYPOGLYCAEMIA 180 0.0037
240 BUNDLE BRANCH BLOCK RIGHT 17 0.0037
241 ISCHAEMIA 17 0.0037
242 TOXIC SKIN ERUPTION 37 0.0037
243 GOITRE 15 0.0037
244 DIVERTICULUM INTESTINAL 16 0.0037
245 IMMUNE-MEDIATED MYOSITIS 10 0.0036
246 PRESYNCOPE 88 0.0036
247 HYPOTONIA 36 0.0036
248 AGRANULOCYTOSIS 67 0.0036
249 CARDIAC FAILURE 287 0.0036
250 COVID-19 PNEUMONIA 42 0.0036
251 GASTROINTESTINAL MOTILITY DISORDER 19 0.0035
252 MITRAL VALVE INCOMPETENCE 40 0.0035
253 INTERVERTEBRAL DISC DISORDER 15 0.0035
254 CREATININE RENAL CLEARANCE DECREASED 14 0.0035
255 ACUTE MYOCARDIAL INFARCTION 103 0.0035
256 TRIGEMINAL NEURALGIA 14 0.0035
257 CORONAVIRUS INFECTION 23 0.0035
258 GENERAL PHYSICAL HEALTH DETERIORATION 402 0.0035
259 SKIN NECROSIS 18 0.0035
260 RALES 20 0.0034
261 HEPATITIS ACUTE 22 0.0034
262 PYELONEPHRITIS 29 0.0033
263 ATYPICAL PNEUMONIA 10 0.0033
264 MYOCARDIAL ISCHAEMIA 38 0.0033
265 HYPOTENSION 669 0.0033
266 ARTERIOSCLEROSIS CORONARY ARTERY 22 0.0033
267 HEPATITIS CHOLESTATIC 20 0.0033
268 INTERSTITIAL LUNG DISEASE 160 0.0033
269 POLYURIA 27 0.0033
270 NOCTURIA 40 0.0033
271 AORTIC ANEURYSM 25 0.0033
272 ANAEMIA 624 0.0033
273 LEFT VENTRICULAR HYPERTROPHY 14 0.0033
274 MIOSIS 26 0.0032
275 MUSCLE HAEMORRHAGE 13 0.0032
276 RENAL FUNCTION TEST ABNORMAL 15 0.0032
277 URINE OUTPUT DECREASED 28 0.0032
278 INTERNATIONAL NORMALISED RATIO ABNORMAL 11 0.0032
279 INTERNATIONAL NORMALISED RATIO INCREASED 91 0.0032
280 SYNCOPE 318 0.0032
281 VASCULITIS 37 0.0032
282 EOSINOPHILIC PNEUMONIA 10 0.0032
283 TACHYPNOEA 43 0.0032
284 GAMMA-GLUTAMYLTRANSFERASE INCREASED 70 0.0032
285 CAROTID ARTERY STENOSIS 11 0.0031
286 IRON DEFICIENCY ANAEMIA 29 0.0031
287 JAUNDICE CHOLESTATIC 11 0.0031
288 ELECTROCARDIOGRAM QT PROLONGED 112 0.0031
289 SUBDURAL HAEMATOMA 44 0.0031
290 HEPATIC LESION 13 0.0030
291 THROMBOCYTOSIS 11 0.0030
292 ATRIOVENTRICULAR BLOCK FIRST DEGREE 13 0.0030
293 DYSPNOEA EXERTIONAL 112 0.0030
294 INTERNATIONAL NORMALISED RATIO DECREASED 12 0.0030
295 ACUTE RESPIRATORY DISTRESS SYNDROME 52 0.0029
296 ABNORMAL LOSS OF WEIGHT 20 0.0029
297 METABOLIC DISORDER 17 0.0029
298 MENISCUS INJURY 18 0.0029
299 CEREBRAL ISCHAEMIA 15 0.0029
300 PERIPHERAL SENSORY NEUROPATHY 17 0.0029
301 GASTRIC ULCER HAEMORRHAGE 16 0.0029
302 CIRCULATORY COLLAPSE 49 0.0029
303 SQUAMOUS CELL CARCINOMA 27 0.0029
304 POLYNEUROPATHY 34 0.0028
305 EJECTION FRACTION DECREASED 44 0.0028
306 PURPURA 25 0.0028
307 ABSCESS LIMB 12 0.0028
308 DIVERTICULUM 20 0.0028
309 BLOOD CREATINE PHOSPHOKINASE INCREASED 81 0.0028
310 HYPERNATRAEMIA 14 0.0028
311 RENAL IMPAIRMENT 236 0.0028
312 NEUTROPENIC SEPSIS 20 0.0028
313 THROMBOCYTOPENIA 313 0.0028
314 MYOSITIS 25 0.0028
315 CONCOMITANT DISEASE AGGRAVATED 17 0.0028
316 STRESS CARDIOMYOPATHY 16 0.0027
317 PULMONARY HYPERTENSION 57 0.0027
318 BURSITIS 33 0.0027
319 ALTERED STATE OF CONSCIOUSNESS 58 0.0027
320 ESCHERICHIA INFECTION 22 0.0027
321 MUCOSAL INFLAMMATION 70 0.0027
322 PARKINSONISM 26 0.0027
323 SPINAL STENOSIS 11 0.0027
324 MYOPATHY 23 0.0027
325 BLOOD PRESSURE INADEQUATELY CONTROLLED 16 0.0027
326 LEUKOCYTOSIS 48 0.0026
327 SUBARACHNOID HAEMORRHAGE 27 0.0026
328 TOXIC EPIDERMAL NECROLYSIS 40 0.0026
329 DRUG LEVEL ABOVE THERAPEUTIC 12 0.0026
330 CONJUNCTIVAL HAEMORRHAGE 10 0.0026
331 ACIDOSIS 20 0.0026
332 ATRIAL FIBRILLATION 254 0.0026
333 JAUNDICE 70 0.0026
334 HYPERTRANSAMINASAEMIA 18 0.0026
335 BRONCHOPULMONARY ASPERGILLOSIS 20 0.0026
336 URINARY RETENTION 86 0.0026
337 CARDIOPULMONARY FAILURE 10 0.0026
338 PRODUCT PRESCRIBING ERROR 61 0.0026
339 CLOSTRIDIUM DIFFICILE COLITIS 27 0.0025
340 LEUKOPENIA 127 0.0025
341 SINUS HEADACHE 15 0.0025
342 BRONCHOSPASM 36 0.0025
343 HEART RATE ABNORMAL 14 0.0025
344 MALABSORPTION 13 0.0025
345 DERMATITIS BULLOUS 18 0.0025
346 ENTEROCOCCAL INFECTION 12 0.0025
347 ECCHYMOSIS 17 0.0025
348 VERTIGO 151 0.0025
349 PERONEAL NERVE PALSY 14 0.0025
350 CEREBRAL HAEMORRHAGE 88 0.0025
351 CYTOPENIA 30 0.0024
352 PULMONARY FIBROSIS 47 0.0024
353 COMA 115 0.0024
354 PERIPHERAL COLDNESS 33 0.0024
355 DERMATITIS EXFOLIATIVE 12 0.0024
356 BLOOD THYROID STIMULATING HORMONE INCREASED 22 0.0024
357 DRUG-INDUCED LIVER INJURY 75 0.0024
358 BLOOD CREATININE INCREASED 156 0.0024
359 ERECTILE DYSFUNCTION 61 0.0024
360 BLOOD PRESSURE FLUCTUATION 57 0.0024
361 NEPHROGENIC ANAEMIA 11 0.0024
362 GASTRIC ULCER 45 0.0024
363 HYPERTHERMIA 18 0.0024
364 BREAST PAIN 25 0.0023
365 ARRHYTHMIA 111 0.0023
366 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 12 0.0023
367 FEMORAL NECK FRACTURE 12 0.0023
368 NECROSIS 13 0.0023
369 PULMONARY ALVEOLAR HAEMORRHAGE 13 0.0023
370 HYPOPHOSPHATAEMIA 17 0.0023
371 PETECHIAE 24 0.0023
372 CHOLECYSTITIS ACUTE 13 0.0023
373 ASPERGILLUS INFECTION 15 0.0023
374 RIGHT VENTRICULAR FAILURE 16 0.0023
375 CORONARY ARTERY DISEASE 69 0.0023
376 HYPERCALCAEMIA 28 0.0023
377 RENAL CYST 18 0.0023
378 ATRIAL FLUTTER 18 0.0023
379 OLIGURIA 14 0.0023
380 HAEMORRHOIDAL HAEMORRHAGE 11 0.0023
381 HEMIPARESIS 38 0.0022
382 VENTRICULAR TACHYCARDIA 37 0.0022
383 BREATH SOUNDS ABNORMAL 11 0.0022
384 OEDEMA PERIPHERAL 271 0.0022
385 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 116 0.0022
386 TRANSIENT ISCHAEMIC ATTACK 75 0.0022
387 BEHAVIOUR DISORDER 12 0.0022
388 PULMONARY MASS 33 0.0022
389 RENAL FAILURE 294 0.0022
390 PULMONARY ARTERIAL HYPERTENSION 32 0.0022
391 IMMUNE THROMBOCYTOPENIA 10 0.0022
392 HYPERLIPIDAEMIA 26 0.0022
393 MUSCLE RIGIDITY 26 0.0022
394 PROTHROMBIN TIME PROLONGED 13 0.0022
395 HYPOTHERMIA 22 0.0022
396 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 11 0.0022
397 LYMPHOEDEMA 15 0.0022
398 UROSEPSIS 20 0.0022
399 HYPERTHYROIDISM 31 0.0021
400 PALLOR 58 0.0021
401 APLASTIC ANAEMIA 11 0.0021
402 BRAIN FOG 33 0.0021
403 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 13 0.0021
404 INTERVERTEBRAL DISC PROTRUSION 46 0.0021
405 CARDIAC TAMPONADE 10 0.0021
406 ANGIOEDEMA 93 0.0021
407 SUPRAVENTRICULAR TACHYCARDIA 20 0.0021
408 DECUBITUS ULCER 17 0.0021
409 HYPERVENTILATION 12 0.0021
410 HYPERTENSION 436 0.0021
411 MOUTH HAEMORRHAGE 15 0.0020
412 INCORRECT DOSAGE ADMINISTERED 10 0.0020
413 HEMIPLEGIA 17 0.0020
414 HEPATIC STEATOSIS 38 0.0020
415 WOUND 57 0.0020
416 HALLUCINATION, VISUAL 43 0.0020
417 HEPATOMEGALY 20 0.0020
418 MUSCULOSKELETAL DISCOMFORT 35 0.0020
419 DIABETES MELLITUS INADEQUATE CONTROL 36 0.0020
420 BRADYKINESIA 12 0.0020
421 CARDIOMEGALY 25 0.0020
422 RENAL FAILURE ACUTE 86 0.0020
423 ARTERIOSCLEROSIS 19 0.0020
424 FACIAL PAIN 18 0.0020
425 HAEMOLYTIC ANAEMIA 18 0.0020
426 ANGINA UNSTABLE 13 0.0020
427 TENDON PAIN 15 0.0020
428 VENTRICULAR FIBRILLATION 22 0.0020
429 DYSPHORIA 10 0.0020
430 SPINAL PAIN 23 0.0020
431 NEPHROPATHY TOXIC 22 0.0020
432 LEFT VENTRICULAR DYSFUNCTION 13 0.0019
433 ANAPHYLACTIC SHOCK 50 0.0019
434 APHTHOUS ULCER 15 0.0019
435 RECTAL HAEMORRHAGE 83 0.0019
436 MICTURITION URGENCY 22 0.0019
437 EPISTAXIS 144 0.0019
438 ACUTE RESPIRATORY FAILURE 37 0.0019
439 EPSTEIN-BARR VIRUS INFECTION 12 0.0019
440 DYSARTHRIA 72 0.0019
441 AFFECTIVE DISORDER 15 0.0019
442 GASTRITIS 50 0.0019
443 PROTEINURIA 36 0.0019
444 JOINT DISLOCATION 20 0.0019
445 SEPTIC SHOCK 82 0.0019
446 HAEMATOCRIT DECREASED 37 0.0019
447 DEFAECATION URGENCY 13 0.0019
448 RESPIRATORY FAILURE 135 0.0018
449 ERYTHEMA OF EYELID 10 0.0018
450 GOUT 33 0.0018
451 LIPASE INCREASED 14 0.0018
452 CORONARY ARTERY OCCLUSION 25 0.0018
453 COLD SWEAT 32 0.0018
454 HAEMATURIA 62 0.0018
455 PULMONARY OEDEMA 81 0.0018
456 BLOOD PRESSURE INCREASED 275 0.0018
457 SPINAL DISORDER 17 0.0018
458 HYPOKINESIA 26 0.0018
459 QUALITY OF LIFE DECREASED 24 0.0018
460 APHASIA 54 0.0018
461 LARYNGEAL OEDEMA 11 0.0018
462 TENDON RUPTURE 22 0.0018
463 GASTROENTERITIS 26 0.0018
464 PANCYTOPENIA 99 0.0018
465 COMPLETED SUICIDE 147 0.0018
466 NEPHROTIC SYNDROME 12 0.0017
467 HYPERTONIA 10 0.0017
468 GLYCOSYLATED HAEMOGLOBIN INCREASED 44 0.0017
469 LUNG DISORDER 85 0.0017
470 RESPIRATORY TRACT INFECTION 45 0.0017
471 PROCTALGIA 11 0.0017
472 HYPERTRIGLYCERIDAEMIA 10 0.0017
473 TUMOUR LYSIS SYNDROME 15 0.0017
474 PNEUMOCYSTIS JIROVECII PNEUMONIA 17 0.0017
475 NEUTROPENIA 230 0.0017
476 TENDON DISORDER 11 0.0017
477 FALL 561 0.0017
478 TENDONITIS 26 0.0017
479 BASAL CELL CARCINOMA 26 0.0017
480 DISORIENTATION 66 0.0017
481 BLOOD POTASSIUM INCREASED 27 0.0017
482 INTENTIONAL OVERDOSE 106 0.0017
483 DIZZINESS POSTURAL 16 0.0016
484 METASTASES TO LUNG 19 0.0016
485 PERICARDIAL EFFUSION 38 0.0016
486 THROMBOTIC MICROANGIOPATHY 16 0.0016
487 SUICIDE ATTEMPT 99 0.0016
488 HAEMOPTYSIS 45 0.0016
489 CHOLANGITIS 10 0.0016
490 SCRATCH 17 0.0016
491 PULMONARY EMBOLISM 153 0.0016
492 BLOOD PRESSURE ABNORMAL 32 0.0016
493 UPPER GASTROINTESTINAL HAEMORRHAGE 27 0.0016
494 FEBRILE NEUTROPENIA 106 0.0016
495 RESTLESS LEGS SYNDROME 29 0.0016
496 C-REACTIVE PROTEIN INCREASED 58 0.0016
497 CONFUSIONAL STATE 257 0.0016
498 INTENTIONAL SELF-INJURY 32 0.0016
499 LOWER RESPIRATORY TRACT INFECTION 72 0.0016
500 CHRONIC KIDNEY DISEASE 120 0.0016
501 PHOTOSENSITIVITY REACTION 26 0.0016
502 TRANSAMINASES INCREASED 35 0.0016
503 MYOCARDITIS 18 0.0016
504 TACHYCARDIA 139 0.0016
505 HAEMARTHROSIS 14 0.0016
506 LYMPHOPENIA 22 0.0016
507 EYELID OEDEMA 18 0.0015
508 HAEMOGLOBIN DECREASED 159 0.0015
509 PLEURAL EFFUSION 94 0.0015
510 HYPERBILIRUBINAEMIA 16 0.0015
511 RENAL TUBULAR NECROSIS 15 0.0015
512 ARTERIAL OCCLUSIVE DISEASE 12 0.0015
513 RESPIRATORY DISTRESS 42 0.0015
514 PSEUDOMONAS INFECTION 13 0.0015
515 HYPERGLYCAEMIA 55 0.0015
516 FEELING COLD 42 0.0015
517 GASTROINTESTINAL HAEMORRHAGE 125 0.0015
518 DYSURIA 55 0.0015
519 CARDIO-RESPIRATORY ARREST 62 0.0015
520 FACE OEDEMA 25 0.0015
521 COLITIS ISCHAEMIC 10 0.0015
522 NEURALGIA 36 0.0015
523 HYPOTHYROIDISM 47 0.0015
524 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 14 0.0015
525 HAEMATEMESIS 37 0.0015
526 MYALGIA 248 0.0015
527 CARDIAC ARREST 120 0.0015
528 PALPITATIONS 170 0.0015
529 DYSPNOEA 819 0.0014
530 NERVE INJURY 16 0.0014
531 AUTOIMMUNE HEPATITIS 10 0.0014
532 HEPATOTOXICITY 32 0.0014
533 BLOOD SODIUM DECREASED 27 0.0014
534 DERMATITIS ALLERGIC 18 0.0014
535 MALNUTRITION 16 0.0014
536 DRY MOUTH 116 0.0014
537 DIFFUSE LARGE B-CELL LYMPHOMA 11 0.0014
538 HYPOALBUMINAEMIA 11 0.0014
539 SLEEP APNOEA SYNDROME 27 0.0014
540 INFLAMMATION 73 0.0014
541 LYMPHADENOPATHY 50 0.0014
542 SEPSIS 157 0.0014
543 EPILEPSY 43 0.0014
544 DEEP VEIN THROMBOSIS 91 0.0014
545 BLOOD PRESSURE DECREASED 93 0.0014
546 TYPE 2 DIABETES MELLITUS 47 0.0014
547 CYTOKINE RELEASE SYNDROME 28 0.0014
548 ASCITES 41 0.0014
549 NEPHROPATHY 13 0.0014
550 ENCEPHALOPATHY 34 0.0014
551 HEPATIC ENZYME INCREASED 94 0.0014
552 DRUG INTOLERANCE 133 0.0014
553 BLOOD UREA INCREASED 23 0.0014
554 CHOLELITHIASIS 45 0.0014
555 COLITIS 52 0.0014
556 HEPATITIS 35 0.0014
557 OEDEMA 74 0.0014
558 INITIAL INSOMNIA 14 0.0014
559 CANDIDA INFECTION 23 0.0014
560 HAEMATOCHEZIA 75 0.0014
561 SECRETION DISCHARGE 17 0.0014
562 SKIN REACTION 19 0.0013
563 THERAPY PARTIAL RESPONDER 21 0.0013
564 HERNIA 26 0.0013
565 MUSCULAR WEAKNESS 152 0.0013
566 ASTHENIA 500 0.0013
567 GENERALISED TONIC-CLONIC SEIZURE 22 0.0013
568 COGNITIVE DISORDER 62 0.0013
569 EMBOLISM 11 0.0013
570 GINGIVAL BLEEDING 18 0.0013
571 SKIN ULCER 34 0.0013
572 SWOLLEN TONGUE 41 0.0013
573 HEART RATE DECREASED 46 0.0013
574 TOXICITY TO VARIOUS AGENTS 220 0.0013
575 DECREASED APPETITE 303 0.0013
576 SHOCK 30 0.0013
577 STAPHYLOCOCCAL INFECTION 43 0.0013
578 BLOOD TRIGLYCERIDES INCREASED 23 0.0013
579 LOSS OF CONSCIOUSNESS 166 0.0013
580 DERMATITIS 27 0.0013
581 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 10 0.0013
582 LETHARGY 74 0.0013
583 PNEUMONITIS 35 0.0013
584 WHEEZING 76 0.0013
585 HAEMORRHOIDS 25 0.0013
586 BONE MARROW FAILURE 26 0.0013
587 BLOOD GLUCOSE FLUCTUATION 14 0.0013
588 BLOOD LACTATE DEHYDROGENASE INCREASED 20 0.0013
589 RED BLOOD CELL COUNT DECREASED 36 0.0013
590 LIVER FUNCTION TEST INCREASED 27 0.0013
591 DRUG PRESCRIBING ERROR 24 0.0012
592 ROTATOR CUFF SYNDROME 16 0.0012
593 BLOOD CALCIUM DECREASED 14 0.0012
594 ATELECTASIS 12 0.0012
595 CHEST PAIN 230 0.0012
596 STATUS EPILEPTICUS 14 0.0012
597 ANAL INCONTINENCE 11 0.0012
598 CARDIOMYOPATHY 18 0.0012
599 DIARRHOEA 779 0.0012
600 DYSPHAGIA 114 0.0012
601 COUGH 335 0.0012
602 SCIATICA 19 0.0012
603 ABDOMINAL PAIN LOWER 30 0.0012
604 MUSCLE ATROPHY 15 0.0012
605 CHEST DISCOMFORT 121 0.0012
606 HEPATIC ENCEPHALOPATHY 11 0.0012
607 MIDDLE INSOMNIA 22 0.0012
608 INADEQUATE ANALGESIA 10 0.0012
609 DIARRHOEA HAEMORRHAGIC 11 0.0012
610 CHOLECYSTITIS 14 0.0012
611 MYOCLONUS 14 0.0012
612 ALANINE AMINOTRANSFERASE INCREASED 72 0.0012
613 DEHYDRATION 156 0.0012
614 HELICOBACTER INFECTION 12 0.0012
615 ASPARTATE AMINOTRANSFERASE INCREASED 62 0.0012
616 DYSPEPSIA 114 0.0012
617 CONTRAINDICATED PRODUCT ADMINISTERED 35 0.0012
618 CHROMATURIA 26 0.0012
619 MEDICATION ERROR 64 0.0012
620 URINARY INCONTINENCE 34 0.0011
621 SOMNOLENCE 231 0.0011
622 SKIN HAEMORRHAGE 17 0.0011
623 GLAUCOMA 22 0.0011
624 HEAD INJURY 36 0.0011
625 OSTEONECROSIS OF JAW 28 0.0011
626 SKIN LESION 31 0.0011
627 ILEUS 14 0.0011
628 THERAPY CHANGE 11 0.0011
629 HYPERHIDROSIS 144 0.0011
630 PARALYSIS 16 0.0011
631 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 26 0.0011
632 DISTURBANCE IN ATTENTION 60 0.0011
633 FAECES DISCOLOURED 24 0.0011
634 UVEITIS 15 0.0011
635 FEMUR FRACTURE 34 0.0011
636 NEUROLEPTIC MALIGNANT SYNDROME 13 0.0011
637 ATAXIA 13 0.0011
638 AGITATION 80 0.0011
639 ECZEMA 57 0.0011
640 RASH MACULAR 38 0.0011
641 NIGHT SWEATS 35 0.0011
642 CYANOSIS 17 0.0011
643 PNEUMONIA ASPIRATION 27 0.0011
644 TOOTH ABSCESS 11 0.0011
645 DIZZINESS 537 0.0011
646 FLATULENCE 61 0.0011
647 BLOOD BILIRUBIN INCREASED 29 0.0011
648 ADRENAL INSUFFICIENCY 13 0.0011
649 PYREXIA 368 0.0011
650 DEPRESSED LEVEL OF CONSCIOUSNESS 42 0.0011
651 DEPRESSED MOOD 56 0.0011
652 SENSORY DISTURBANCE 17 0.0011
653 EYE HAEMORRHAGE 14 0.0010
654 DRUG ABUSE 87 0.0010
655 ABDOMINAL PAIN 243 0.0010
656 MOUTH ULCERATION 22 0.0010
657 NEOPLASM 12 0.0010
658 END STAGE RENAL DISEASE 19 0.0010
659 DIPLOPIA 27 0.0010
660 OSTEOARTHRITIS 44 0.0010
661 RENAL PAIN 11 0.0010
662 DEMENTIA 29 0.0010
663 METASTASES TO BONE 17 0.0010
664 HOT FLUSH 78 0.0010
665 GYNAECOMASTIA 32 0.0010
666 MUSCULOSKELETAL CHEST PAIN 16 0.0010
667 WEIGHT DECREASED 286 0.0010
668 COAGULOPATHY 17 0.0010
669 CONDITION AGGRAVATED 310 0.0010
670 TREMOR 169 0.0010
671 HEART RATE IRREGULAR 23 0.0010
672 GASTROINTESTINAL DISORDER 91 0.0010
673 ACCIDENTAL OVERDOSE 37 0.0010
674 HEPATIC CIRRHOSIS 19 0.0010
675 PRODUCT AVAILABILITY ISSUE 23 0.0010
676 THIRST 18 0.0010
677 RASH ERYTHEMATOUS 48 0.0010
678 PNEUMONIA 325 0.0010
679 SLEEP DISORDER 70 0.0010
680 ORAL CANDIDIASIS 13 0.0010
681 PULMONARY CONGESTION 13 0.0010
682 PRODUCTIVE COUGH 47 0.0010
683 NIGHTMARE 34 0.0010
684 OCULAR DISCOMFORT 11 0.0010
685 TINNITUS 45 0.0010
686 GENERALISED OEDEMA 12 0.0010
687 HEART RATE INCREASED 96 0.0010
688 METASTASES TO LIVER 17 0.0010
689 NECK PAIN 54 0.0010
690 BLOOD CHOLESTEROL INCREASED 45 0.0010
691 BLOOD POTASSIUM DECREASED 29 0.0010
692 BALANCE DISORDER 83 0.0010
693 RESTLESSNESS 35 0.0010
694 SPEECH DISORDER 50 0.0010
695 IMPAIRED GASTRIC EMPTYING 13 0.0010
696 MULTIPLE ORGAN DYSFUNCTION SYNDROME 27 0.0010
697 SPINAL FRACTURE 19 0.0009
698 CENTRAL NERVOUS SYSTEM LESION 13 0.0009
699 HALLUCINATION, AUDITORY 15 0.0009
700 CEREBRAL INFARCTION 23 0.0009
701 GAIT DISTURBANCE 180 0.0009
702 RETCHING 20 0.0009
703 PRODUCT SUBSTITUTION ISSUE 54 0.0009
704 VOMITING 440 0.0009
705 HALLUCINATION 70 0.0009
706 BLOOD ALKALINE PHOSPHATASE INCREASED 23 0.0009
707 OXYGEN SATURATION DECREASED 52 0.0009
708 BLOOD PRESSURE SYSTOLIC INCREASED 18 0.0009
709 AGEUSIA 23 0.0009
710 DRY EYE 46 0.0009
711 MALAISE 403 0.0009
712 SINUS TACHYCARDIA 13 0.0009
713 NEUTROPHIL COUNT DECREASED 37 0.0009
714 COVID-19 159 0.0009
715 CARDIOVASCULAR DISORDER 23 0.0009
716 PRESCRIBED UNDERDOSE 18 0.0009
717 FOOT DEFORMITY 10 0.0009
718 NERVOUS SYSTEM DISORDER 28 0.0009
719 RASH PAPULAR 20 0.0009
720 JOINT INJURY 19 0.0009
721 SEIZURE 102 0.0009
722 PNEUMOTHORAX 14 0.0009
723 PEMPHIGUS 11 0.0009
724 ERUCTATION 17 0.0009
725 POISONING 11 0.0009
726 CHOLECYSTECTOMY 10 0.0009
727 URINARY TRACT INFECTION 149 0.0009
728 MENTAL DISORDER 38 0.0009
729 FUNGAL INFECTION 29 0.0009
730 DIVERTICULITIS 24 0.0009
731 LIVER FUNCTION TEST ABNORMAL 25 0.0009
732 MUSCULOSKELETAL PAIN 45 0.0009
733 LIVER DISORDER 38 0.0009
734 PERIPHERAL SWELLING 132 0.0009
735 DEVICE OCCLUSION 12 0.0009
736 PANCREATITIS 45 0.0009
737 ABDOMINAL PAIN UPPER 175 0.0008
738 ERYTHEMA 174 0.0008
739 PSYCHOMOTOR HYPERACTIVITY 14 0.0008
740 BACTERAEMIA 10 0.0008
741 PRODUCT ADMINISTRATION ERROR 17 0.0008
742 GALLBLADDER DISORDER 15 0.0008
743 DELIRIUM 29 0.0008
744 RASH PRURITIC 45 0.0008
745 PRESCRIBED OVERDOSE 16 0.0008
746 CEREBROVASCULAR ACCIDENT 140 0.0008
747 BRONCHITIS 61 0.0008
748 HYPOXIA 29 0.0008
749 BONE DISORDER 15 0.0008
750 APATHY 12 0.0008
751 MALIGNANT MELANOMA 11 0.0008
752 ABDOMINAL DISTENSION 85 0.0008
753 DRUG EFFECT LESS THAN EXPECTED 12 0.0008
754 CATARACT 48 0.0008
755 RESPIRATORY DISORDER 24 0.0008
756 SEDATION 21 0.0008
757 MUSCLE SPASMS 147 0.0008
758 MALIGNANT NEOPLASM PROGRESSION 82 0.0008
759 OCULAR HYPERAEMIA 38 0.0008
760 PHOTOPHOBIA 15 0.0008
761 HEPATIC FAILURE 24 0.0008
762 LYMPHOCYTE COUNT DECREASED 14 0.0008
763 HEAD DISCOMFORT 14 0.0008
764 DRUG ERUPTION 14 0.0008
765 CYSTITIS 25 0.0008
766 HYPOPHAGIA 20 0.0008
767 WHITE BLOOD CELL COUNT INCREASED 30 0.0008
768 FEAR 21 0.0008
769 THERAPY NON-RESPONDER 35 0.0008
770 NAUSEA 614 0.0008
771 DIALYSIS 11 0.0008
772 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 55 0.0008
773 DELUSION 12 0.0008
774 HEADACHE 484 0.0008
775 PARAESTHESIA 121 0.0008
776 PANIC ATTACK 28 0.0008
777 NEUROPATHY PERIPHERAL 73 0.0008
778 FEELING HOT 47 0.0008
779 KIDNEY INFECTION 15 0.0008
780 PARAESTHESIA ORAL 11 0.0008
781 CONSTIPATION 166 0.0008
782 BURNING SENSATION 53 0.0008
783 OBESITY 12 0.0008
784 POLLAKIURIA 31 0.0007
785 SKIN CANCER 16 0.0007
786 MUSCLE TIGHTNESS 12 0.0007
787 DRUG RESISTANCE 19 0.0007
788 MUSCLE TWITCHING 17 0.0007
789 CHILLS 86 0.0007
790 EYE DISORDER 24 0.0007
791 FATIGUE 567 0.0007
792 INSOMNIA 193 0.0007
793 ANAPHYLACTIC REACTION 40 0.0007
794 SUICIDAL IDEATION 66 0.0007
795 STEVENS-JOHNSON SYNDROME 16 0.0007
796 TOOTHACHE 13 0.0007
797 COORDINATION ABNORMAL 10 0.0007
798 INTESTINAL OBSTRUCTION 27 0.0007
799 CARPAL TUNNEL SYNDROME 10 0.0007
800 BLOOD TEST ABNORMAL 10 0.0007
801 DIABETES MELLITUS 54 0.0007
802 NERVOUSNESS 37 0.0007
803 IMPAIRED WORK ABILITY 15 0.0007
804 CONJUNCTIVITIS 13 0.0007
805 UNRESPONSIVE TO STIMULI 18 0.0007
806 VISUAL ACUITY REDUCED 23 0.0007
807 MEMORY IMPAIRMENT 95 0.0007
808 ULCER 11 0.0007
809 FEEDING DISORDER 14 0.0007
810 PRODUCT USE IN UNAPPROVED INDICATION 171 0.0007
811 CLOSTRIDIUM DIFFICILE INFECTION 15 0.0007
812 ARTHRITIS 54 0.0007
813 NEUROTOXICITY 12 0.0007
814 BACK PAIN 159 0.0007
815 PRURITUS 263 0.0007
816 DISEASE PROGRESSION 80 0.0007
817 SWELLING FACE 44 0.0007
818 PAIN IN EXTREMITY 199 0.0007
819 HAEMORRHAGE INTRACRANIAL 10 0.0007
820 OFF LABEL USE 584 0.0007
821 PLATELET COUNT DECREASED 71 0.0007
822 MYOCARDIAL INFARCTION 116 0.0007
823 WEIGHT INCREASED 148 0.0007
824 EATING DISORDER 14 0.0007
825 EYE PRURITUS 22 0.0007
826 ARTHRALGIA 271 0.0007
827 MUSCULOSKELETAL STIFFNESS 57 0.0006
828 BLOOD GLUCOSE ABNORMAL 12 0.0006
829 HERPES ZOSTER 37 0.0006
830 PSORIATIC ARTHROPATHY 26 0.0006
831 DYSKINESIA 26 0.0006
832 MULTI-ORGAN FAILURE 11 0.0006
833 ANXIETY 181 0.0006
834 FRACTURE 12 0.0006
835 LIP SWELLING 21 0.0006
836 VISUAL IMPAIRMENT 78 0.0006
837 RASH GENERALISED 16 0.0006
838 ORAL HERPES 12 0.0006
839 SKIN DISCOLOURATION 28 0.0006
840 JOINT SWELLING 73 0.0006
841 CYTOMEGALOVIRUS INFECTION 10 0.0006
842 PRURITUS GENERALISED 13 0.0006
843 INFECTION 87 0.0006
844 ABDOMINAL DISCOMFORT 100 0.0006
845 HAEMORRHAGE 62 0.0006
846 DISEASE RECURRENCE 28 0.0006
847 CARDIAC DISORDER 55 0.0006
848 MOOD ALTERED 16 0.0006
849 OSTEOPOROSIS 24 0.0006
850 INTENTIONAL PRODUCT USE ISSUE 51 0.0006
851 HYPOACUSIS 25 0.0006
852 DEPRESSION 132 0.0006
853 OVERDOSE 125 0.0006
854 PERITONITIS 12 0.0006
855 THERAPEUTIC RESPONSE SHORTENED 19 0.0006
856 CARDIAC FAILURE CONGESTIVE 46 0.0006
857 CONTUSION 55 0.0006
858 NEPHROLITHIASIS 26 0.0006
859 ASTHMA 64 0.0006
860 DYSPHONIA 33 0.0006
861 HIP FRACTURE 18 0.0006
862 RASH 243 0.0006
863 POOR QUALITY SLEEP 12 0.0006
864 DISCOMFORT 34 0.0006
865 THROAT IRRITATION 25 0.0006
866 BLISTER 31 0.0006
867 FLUID RETENTION 28 0.0005
868 LIMB DISCOMFORT 17 0.0005
869 ABNORMAL DREAMS 15 0.0005
870 UPPER RESPIRATORY TRACT INFECTION 25 0.0005
871 PROCEDURAL PAIN 15 0.0005
872 RENAL INJURY 16 0.0005
873 AMNESIA 35 0.0005
874 DEAFNESS 14 0.0005
875 GASTROOESOPHAGEAL REFLUX DISEASE 43 0.0005
876 LACRIMATION INCREASED 16 0.0005
877 CONVULSION 30 0.0005
878 EXTRAPYRAMIDAL DISORDER 13 0.0005
879 HYPERSOMNIA 15 0.0005
880 SKIN EXFOLIATION 44 0.0005
881 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 25 0.0005
882 BLOOD GLUCOSE INCREASED 98 0.0005
883 NEOPLASM PROGRESSION 18 0.0005
884 EYE PAIN 29 0.0005
885 BONE PAIN 30 0.0005
886 SKIN DISORDER 17 0.0005
887 RESPIRATORY ARREST 14 0.0005
888 PSORIASIS 65 0.0005
889 THROMBOSIS 40 0.0005
890 OROPHARYNGEAL PAIN 46 0.0005
891 CELLULITIS 25 0.0005
892 MENTAL IMPAIRMENT 12 0.0005
893 STOMATITIS 30 0.0005
894 PRODUCT DOSE OMISSION IN ERROR 14 0.0005
895 ORAL PAIN 11 0.0005
896 IMPAIRED HEALING 16 0.0005
897 EYE IRRITATION 28 0.0005
898 PAIN OF SKIN 13 0.0005
899 SWELLING 45 0.0005
900 VIRAL INFECTION 16 0.0005
901 INTENTIONAL PRODUCT MISUSE 42 0.0005
902 LIMB INJURY 13 0.0005
903 TREATMENT NONCOMPLIANCE 26 0.0005
904 GASTRIC DISORDER 16 0.0005
905 SURGERY 27 0.0005
906 DRUG INEFFECTIVE 605 0.0005
907 INFLUENZA 51 0.0005
908 EYE SWELLING 17 0.0005
909 ILLNESS 47 0.0005
910 INTENTIONAL DOSE OMISSION 13 0.0005
911 URTICARIA 75 0.0004
912 PRODUCT USE ISSUE 84 0.0004
913 VISION BLURRED 61 0.0004
914 THROAT TIGHTNESS 12 0.0004
915 MOVEMENT DISORDER 14 0.0004
916 MOBILITY DECREASED 31 0.0004
917 THERAPY CESSATION 22 0.0004
918 DYSGEUSIA 31 0.0004
919 HYPERSENSITIVITY 77 0.0004
920 HYPOAESTHESIA 62 0.0004
921 DRY SKIN 55 0.0004
922 RENAL DISORDER 19 0.0004
923 FOETAL EXPOSURE DURING PREGNANCY 33 0.0004
924 INFLUENZA LIKE ILLNESS 33 0.0004
925 WHITE BLOOD CELL COUNT DECREASED 43 0.0004
926 THERAPEUTIC RESPONSE DECREASED 24 0.0004
927 PAIN 243 0.0004
928 GAIT INABILITY 13 0.0004
929 PANCREATIC CARCINOMA 11 0.0004
930 DYSSTASIA 11 0.0004
931 NASAL CONGESTION 22 0.0004
932 LABORATORY TEST ABNORMAL 11 0.0004
933 ALOPECIA 73 0.0004
934 FEELING ABNORMAL 87 0.0004
935 TREATMENT FAILURE 30 0.0004
936 ARTHROPATHY 20 0.0004
937 RENAL CANCER 17 0.0004
938 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 62 0.0003
939 MIGRAINE 32 0.0003
940 OSTEONECROSIS 11 0.0003
941 FLUSHING 33 0.0003
942 PRODUCT DOSE OMISSION ISSUE 95 0.0003
943 THERAPY INTERRUPTED 23 0.0003
944 HEPATIC FUNCTION ABNORMAL 12 0.0003
945 NASOPHARYNGITIS 58 0.0003
946 SINUSITIS 32 0.0003
947 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 62 0.0003
948 ABNORMAL BEHAVIOUR 12 0.0003
949 AGGRESSION 15 0.0003
950 RHINORRHOEA 19 0.0003
951 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 16 0.0003
952 COLITIS ULCERATIVE 13 0.0003
953 THERAPEUTIC PRODUCT EFFECT DECREASED 13 0.0003
954 SKIN IRRITATION 13 0.0003
955 PLASMA CELL MYELOMA 11 0.0003
956 DEVICE DISLOCATION 12 0.0003
957 HOSPITALISATION 42 0.0003
958 EXTRA DOSE ADMINISTERED 11 0.0003
959 ADVERSE DRUG REACTION 24 0.0003
960 IRRITABILITY 16 0.0003
961 INFUSION RELATED REACTION 17 0.0003
962 INJURY 18 0.0003
963 BLINDNESS 10 0.0002
964 THERAPEUTIC RESPONSE UNEXPECTED 11 0.0002
965 PROSTATE CANCER 19 0.0002
966 RHEUMATOID ARTHRITIS 26 0.0002
967 ADVERSE EVENT 21 0.0002
968 DEATH 193 0.0002
969 MATERNAL EXPOSURE DURING PREGNANCY 19 0.0002
970 UNEVALUABLE EVENT 16 0.0002
971 ACNE 16 0.0002
972 DERMATITIS ATOPIC 11 0.0002
973 BLOOD GLUCOSE DECREASED 10 0.0002
974 ILL-DEFINED DISORDER 12 0.0002
975 INCORRECT DOSE ADMINISTERED 44 0.0002
976 MULTIPLE SCLEROSIS RELAPSE 13 0.0002
977 ACCIDENTAL EXPOSURE TO PRODUCT 19 0.0002
978 SKIN BURNING SENSATION 13 0.0002
979 UNDERDOSE 13 0.0002
980 EXPOSURE DURING PREGNANCY 11 0.0002
981 INJECTION SITE HAEMORRHAGE 13 0.0002
982 INJECTION SITE PAIN 45 0.0001
983 INJECTION SITE SWELLING 11 0.0001
984 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 10 0.0001
985 BREAST CANCER 13 0.0001
986 PRODUCT STORAGE ERROR 12 0.0001
987 DEVICE ISSUE 12 0.0001
988 PRODUCT QUALITY ISSUE 18 0.0001
989 EMOTIONAL DISTRESS 15 0.0001
990 INJECTION SITE ERYTHEMA 13 0.0001
991 DRUG DEPENDENCE 14 0.0001
992 NO ADVERSE EVENT 14 0.0001
993 DRUG DOSE OMISSION 11 0.0001